Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 1, 2007, Pages 59-64

  Cawood, T J ^a   Moriarty, P ^b   O'Farrelly, C ^a,c   O'Shea, D ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 ANTIBODY;

ADIPOGENESIS; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; SMOKING;

EID: 33846107566     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1824     Document Type: Article

References (43)

1. Prabhakar BS, Bahn RS, Smith TJ 2003 Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24:802-835
2. Cawood T, Moriarty P, O'Shea D 2004 Recent developments in thyroid eye disease. BMJ 329:385-390
3. Shine B, Fells P, Edwards OM, Weetman AP 1990 Association between Graves' ophthalmopathy and smoking. Lancet 335:1261-1263
4. Winsa B, Mandahl A, Karlsson FA 1993 Graves' disease, endocrine ophthalmopathy and smoking. Acta Endocrinol (Copenh) 128:156-160
5. Bartalena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F, Loviselli A, Pinchera A 1989 More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest 12:733-737
6. Prummel MF, Wiersinga WM 1993 Smoking and risk of Graves' disease. JAMA 269:479-482
7. Hegedius L, Brix TH, Vestergaard P 2004 Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest 27:265-271
8. Hagg E, Asplund K 1987 Is endocrine ophthalmopathy related to smoking? Br Med J (Clin Res Ed) 295:634-635
9. Pfeilschifter J, Ziegler R 1996 Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf) 45:477-481
10. Eckstein A, Quadbeck B, Mueller G, Rettenmeier AW, Hoermann R, Mann K, Steuhl P, Esser J 2003 Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol 87:773-776
11. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A 1998 Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 129:632-635
12. Bartalena L, Wiersinga WM, Pinchera A 2004 Graves' ophthalmopathy: state of the art and perspectives. J Endocrinol Invest 27:295-301
13. Burch HB, Lahiri S, Bahn RS, Barnes S 1997 Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy. Exp Eye Res 65:311-316
14. Pryor WA, Stone K 1993 Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 686:12-27; discussion 27-28
15. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I 2006 Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 291:L46-L57
16. Metcalfe RA, Weetman AP 1994 Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf) 40:67-72
17. Mack WP, Stasior GO, Cao HJ, Stasior OG, Smith TJ 1999 The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy. Ophthal Plast Reconstr Surg 15:260-271
18. Bertelsen JB, Hegedus L 1994 Cigarette smoking and the thyroid. Thyroid 4:327-331
19. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D 2006 The Effects of TNF and IL-1 on an in vitro model of thyroid associated ophthalmopathy: contrasting effects on adipogenesis. Eur J Endocrinol 155:395-403
20. Bahn RS, Gorman CA, Woloschak GE, David CS, Johnson PM, Johnson CM 1987 Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab 65:665-670
21. Bernhard D, Huck CW, Jakschitz T, Pfister G, Henderson B, Bonn GK, Wick G 2004 Development and evaluation of an in vitro model for the analysis of cigarette smoke effects on cultured cells and tissues. J Pharmacol Toxicol Methods 50:45-51
22. Granowitz EV, Porat R, Mier JW, Pribble JP, Stiles DM, Bloedow DC, Catalano MA, Wolff SM, Dinarello CA 1992 Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 4:353-360
23. Sorisky A, Pardasani D, Gagnon A, Smith TJ 1996 Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab 81:3428-3431
24. Valyasevi RW, Erickson DZ, Harteneck DA, Dutton CM, Heufelder AE, Jyonouchi SC, Bahn RS 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 84:2557-2562
25. Valyasevi RW, Jyonouchi SC, Dutton CM, Munsakul N, Bahn RS 2001 Effect of tumor necrosis factor-α, interferon-γ, and transforming growth factor-β on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 86:903-908
26. Valyasevi RW, Harteneck DA, Dutton CM, Bahn RS 2002 Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 87:2352-2358
27. Hemmrich K, von Heimburg D, Cierpka K, Haydarlioglu S, Pallua N 2005 Optimization of the differentiation of human preadipocytes in vitro. Differentiation 73:28-35
28. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W 1992 Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 97:493-497
29. Hoshino Y, Mio T, Nagai S, Miki H, Ito I, Izumi T 2001 Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am J Physiol Lung Cell Mol Physiol 281:L509-L516
30. Ishii T, Matsuse T, Igarashi H, Masuda M, Teramoto S, Ouchi Y 2001 Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase P1. Am J Physiol Lung Cell Mol Physiol 280:L1189-L1195
31. Oltmanns U, Chung KF, Walters M, John M, Mitchell JA 2005 Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle. Respir Res 6:74
32. 2-induced cell death from apoptosis to necrosis in U937 cells. Immunol Lett 72:163-166
33. Vayssier-Taussat M, Camilli T, Aron Y, Meplan C, Hainaut P, Polla BS, Weksler B 2001 Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am J Physiol Heart Circ Physiol 280:H1293-H1300
34. Bahn RS 1995 The fibroblast is the target cell in the connective tissue manifestations of Graves' disease. Int Arch Allergy Immunol 106:213-218
35. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF 2003 TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 58:280-287
36. Bahn RS, Heufelder AE 1993 Pathogenesis of Graves' ophthalmopathy. N Engl J Med 329:1468-1475
37. Werner SC, Coleman DJ, Franzen LA 1974 Ultrasonographic evidence of a consistent orbital involvement in Graves's disease. N Engl J Med 290:1447-1450
38. Ahn KS, Aggarwal BB 2005 Transcription factor NF-κB: a sensor for smoke and stress signals. Ann NY Acad Sci 1056:218-233
39. Wakelkamp IM, Gerding MN, van der Meer JW, Prummel MF, Wiersinga WM 2002 Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy. Clin Exp Immunol 127:316-320
40. Holm IA, Manson JE, Michels KB, Alexander EK, Willett WC, Utiger RD 2005 Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Arch Intern Med 165:1606-1611
41. Vestergaard P, Rejnmark L, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Laurberg P, Mosekilde L 2002 Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 12:69-75
42. Krassas GE, Wiersinga W 2006 Smoking and autoimmune thyroid disease: the plot thickens. Eur J Endocrinol 154:777-780
43. Baginski TK, Dabbagh K, Satjawatcharaphong C, Swinney DC 2006 Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. Am J Respir Cell Mol Biol 35:165-174